Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

119 results about "Competitive binding" patented technology

Competitive binding assay. n. An assay in which a biologically specific binding agent competes for radioactively labeled or unlabeled compounds, used especially to measure the concentration of hormone receptors in a sample by introducing a radioactively labeled hormone.

Method for repairing soil heavy metal pollution by coupling soybean urease with biochar cementing agent

The invention discloses a method for restoring soil heavy metal pollution by coupling soybean urease with a charcoal cementing agent, and relates to the technical field of soil heavy metal pollution restoration, and the method comprises the following steps: dynamic microbiome regulation and control: introducing photosensitive protein into soil functional bacteria; the acyl homoserine lactone analogue is synthesized and applied to soil, and is competitively combined with a microbial quorum sensing receptor to block an inhibitor to secrete a signal channel; according to the method, microbial urease secretion is regulated and controlled through optogenetics, an inhibitor signal is blocked through quorum sensing interference, and a microbiome is precisely regulated and controlled; the pH-responsive nanocapsule releases an inhibitor in a targeted manner, and the magnetic-responsive nanochain dynamically captures interfering bacteria, so that the limitation of passive adsorption is broken through; the gene editing plant releases coumarin to inhibit fungal metabolism, and the engineering mycorrhizal fungi physically shields an inhibitor to construct cross-biosphere cooperative defense; the urease activity and the heavy metal removal rate are remarkably improved, meanwhile, the soil microbial diversity is maintained, and the soil specificity interference problem is solved.
Owner:GUANGDONG OCEAN UNIVERSITY

Application of detection reagent for hair follicle development related genes of down producing goat

The invention relates to the technical field of gene engineering, in particular to application of a detection reagent for a hair follicle development related gene of a down producing goat. According to the present invention, the Cashmere goat hair follicle development related gene is any one or more of lncRNA MSTRG.20890.1, chi-miR-24-3p and ADAMTS3, and the lncRNA MSTRG.20890.1 and the ADAMTS3 are competitively combined with the chi-miR-24-3p, such that the significant differential expression of the lncRNA MSTRG.20890.1 in the Cashmere goat secondary hair follicle morphogenesis process is found, and the results prove that the lncRNA MSTRG.20890.1 can regulate the proliferation and the migration of dermal fibroblasts through the competitive combination of the lncRNA MSTRG.20890.1 and the ADAMTS3, such that the growth of the Cashmere goat secondary hair follicle morphogenesis can be inhibited therefore, the formation of a dermal papilla structure is inhibited.
Owner:INNER MONGOLIA AGRICULTURAL UNIVERSITY

Antibody for detecting indoxyl sulfate, detection kit and application thereof

The invention discloses an antibody for detecting indol sulfate, a detection kit and application of the antibody, and the antibody can be specifically combined with indol sulfate and has high combination activity. The detection kit detects the content of indoxyl sulfate in a to-be-detected sample through a competitive binding reaction of an immunomagnetic bead coated indoxyl sulfate antibody, an antigen in the sample and an alkaline phosphatase labeled indoxyl sulfate antigen, and has important economic value and social significance.
Owner:FIRST AFFILIATED HOSPITAL OF DALIAN MEDICAL UNIV

Anti-CD40 monoclonal antibody and application thereof

The invention provides an anti-CD40 monoclonal antibody and application of the anti-CD40 monoclonal antibody. The anti-CD40 monoclonal antibody comprises three heavy chain complementarity determining regions (HCDR1, HCDR2 and HCDR3) as shown in SEQ ID NOs: 1-3, and three light chain complementarity determining regions (LCDR1, LCDR2 and LCDR3) as shown in SEQ ID NO: 4, YAS and SEQ ID NO: 5. The antibody has binding activity with in-vitro CD40 and CD40 on the cell surface, and can be competitively bound with CD40L to block binding of the antibody and CD40L so as to inhibit CD40 / CD40L signal transduction and inhibit B cell proliferation and activation, so that immune overexpression and rejection can be inhibited. Therefore, when the antibody is applied to preparation of drugs for treating immune diseases, the antibody has the advantages of high targeting specificity, high affinity, few side effects and the like, and has a great application prospect.
Owner:FUWAI HOSPITAL CHINESE ACAD OF MEDICAL SCI & PEKING UNION MEDICAL COLLEGE

Method for analyzing interaction between procambarus clarkia arginine kinase and shark source nano antibody

The invention provides a method for analyzing interaction between procambarus clarkia arginine kinase and shark source nano antibody. The method comprises the following steps: performing three-dimensional structure prediction on a VNAR sequence, and screening a high-confidence VNAR model by using a Laplace map; docking an amino acid sequence corresponding to the VNAR model with an arginine kinase sequence to obtain an optimal compound model, and analyzing an interaction site of an arginine kinase epitope region and a nanometer antibody complementary determining region CDR3; performing molecular dynamics simulation on the compound model, calculating conformational change indexes and binding free energy through energy optimization, system balance and extended simulation sampling, and outputting a binding stability sequence of the nano antibody and arginine kinase; the method comprises the following steps: screening out a high-stability nano antibody, pre-incubating a fusion protein of the high-stability nano antibody and immobilized arginine kinase to form a compound, adding serum of an allergic patient for competitive binding, quantifying the binding activity of residual IgE through an immunodetection technology, and verifying the inhibition effect of the shark source nano antibody on the sensitization effect of arginine kinase.
Owner:XIAMEN HUAXIA UNIV

Application of lnc-RNF219-3: 1 and related biological element thereof in deep venous thrombosis diagnosis and treatment

The invention belongs to the technical field of biological medicine and molecular biology, and particularly relates to application of lnc-RNF219-3: 1 and related biological elements thereof in deep vein thrombosis diagnosis and treatment. The invention discloses the pathogenesis of deep vein thrombosis participated by an lnc-RNF219-3: 1 / miR-93-5p / Tim-4 signal axis, and tests prove that the inhibition effect of targeted combination of miR-93-5p and Tim-4 is reduced by over-expressing lnc-RNF219-3: 1 through competitive combination of lnc-RNF219-3: 1 and Tim-4, so that the expression of Tim-4 is up-regulated, and the thrombosis process is inhibited. Meanwhile, the three markers have good diagnostic value for deep venous thrombosis, so that the three markers can be used as new biomarkers and targets for clinical diagnosis and treatment of deep venous thrombosis, and have good practical application value.
Owner:SHANDONG FIRST MEDICAL UNIV & SHANDONG ACADEMY OF MEDICAL SCI

And theaflavin-3apos; application of gallate and medicine prepared from gallate

The invention belongs to the technical field of pharmacotherapeutics, and particularly relates to application of theaflavin-3 '-gallate and a medicine prepared from theaflavin-3'-gallate. The theaflavin-3 '-gallate is used as a KEAP1-NRF2 inhibitor and is competitively combined with the KEAP1 to destroy the inhibition effect of the KEAP1 on the NRF2, so that the content of the NRF2 is increased, and the expression of downstream NQO1 and GCLC is improved. Besides, the theaflavin-3 '-gallate protects the liver function by inhibiting the increase of the contents of AST and ALT, and reduces the oxidative stress and lipid accumulation of the liver, so that the theaflavin-3'-gallate has the potential to become a medicine for treating the ethanol-induced liver injury.
Owner:ANHUI MEDICAL UNIV

Attractant for termites and screening method thereof

The invention relates to the technical field of termite prevention and control, and particularly discloses an attractant for termites and a screening method thereof.The attractant comprises one or more of a (1R)-(+)-alpha-pinene solution and a eudesmol solution; the screening method for the termite attractant comprises the following steps: acquiring an antenna template and an odorant binding protein gene sequence of termites; obtaining plant volatile matters; obtaining an odor binding protein gene based on the odor binding protein gene sequence, and expressing odor binding protein through a prokaryotic expression system based on the odor binding protein gene to obtain odor binding protein; and determining the binding capacity of the odor binding protein and each odor component in the plant volatile matter by adopting a fluorescent competitive binding test so as to obtain the attractant component for the termites. The attractant is stable in attraction effect, termites can be accurately and efficiently attracted out from hidden places to be killed, and large-area use of killing agents for prevention and control is not needed.
Owner:HUNAN TONGDA BIOTECHNOLOGY CO LTD

Antigen-binding protein and use thereof

The present application relates to an antigen-binding protein and use thereof, and specifically relates to an antigen-binding protein capable of inhibiting competitive binding of IGF-IR to ligands thereof with an IC50 value of about 1.0 μg / mL or less in a competitive ELISA.
Owner:MINGHUI PHARMA HANGZHOU LTD +1

Application of Brazilian circular nematode FAR-1 protein as anti-nematode drug target

The invention discloses an application of a Brazilian strongylus FAR-1 protein as an anti-nematode drug target. A fluorescent ligand competitive binding experiment shows that the Japanese strongylus Brazil FAR-1 protein has the capability of binding various fatty acids and retinol; the Nbfar-1 gene is in high expression in the whole development stage of the Brazilian strongylus; nbfar-1 gene expression is inhibited through RNAi, the lipid content of larvae can be reduced, the adult egg laying rate, the egg hatching rate, larva development and adult epidermis formation are affected, and therefore growth and development of Brazilian strongylus are remarkably affected. Therefore, the Brazilian circular nematode FAR-1 protein can be used as a drug target for screening or identifying anti-parasitic nematode drugs, a method is provided for development of the anti-parasitic nematode drugs, and the Brazilian circular nematode FAR-1 protein has important significance on prevention and treatment of infection of parasitic nematodes.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Autophagy inhibitory polypeptide of targeted LIR region and application of autophagy inhibitory polypeptide

The invention relates to the fields of pharmacology and molecular biology, and discloses an autophagy inhibitory polypeptide competitively combined with an LIR docking site of an autophagy-related protein LC3 and application of the autophagy inhibitory polypeptide. Through molecular docking simulation, through LIR docking sites of targeted LC3 protein, 794 bioactive polypeptides which can be combined are screened out. Functional result analysis shows that peptide 3 #, peptide 4 # and peptide 5 # are competitively combined with LIR docking sites of the LC3 protein, so that formation of autophagy vesicles is inhibited in a targeted manner, and proliferation and survival of autophagy-dependent pancreatic cancer cells are effectively inhibited; the strategy is combined with chemotherapeutic drugs to show a synergistic effect, and the pancreatic cancer resisting curative effect is remarkably enhanced.
Owner:ZHEJIANG PROVINCIAL PEOPLES HOSPITAL

Small molecule inhibitors and preparation methods and their use in the preparation of anticancer drugs

The present invention belongs to the field of biomedicine technology, and relates to small molecule inhibitors and preparation methods and their applications in the preparation of anticancer drugs. Its chemical structural formula is shown in formula (I), and the small molecule inhibitors provided by the present invention have good competitive affinity for the β-catenin / BCL9 target, and can be tightly bound to the target, and have a strong ability to competitively bind to destroy the β-catenin / BCL9 complex. Among them, some small molecule inhibitors have excellent inhibitory effects on the expression of the target gene Axin and better biological activity.
Owner:SHANDONG ACADEMY OF PHARMACEUTICAL SCIENCES

Use of hegl, hegl monoclonal antibodies and use in tumor therapy

The application belongs to the technical field of biological medicine, and particularly relates to the application of HEG1, HEG1 monoclonal antibody and the application in tumor treatment. It is proved that HEG1 is an immune checkpoint molecule with NK cell as an action target on the surface of tumor cells. The application provides the sequence of the HEG1 monoclonal antibody. The HEG1 monoclonal antibody has high specificity and high affinity for the HEG1 protein on the surface of tumor cells, can compete with HEG1 to bind and mediate the recognition and killing of natural killer cells NK cells on tumor cells, and block the immune escape. The application provides a new gene and direction for the treatment of tumors, provides an innovative idea for the development of precise targeted drugs, and has important conversion value and clinical application prospect in the field of tumor treatment.
Owner:ANHUI MEDICAL UNIV

A single-molecule quantitative detection method for T-2 toxin in cereals

The present invention relates to the technical field of food safety detection, and in particular to a method for quantitative detection of T-2 toxin at the single molecule level in cereals. The sample to be tested is mixed with a detection probe to release a DNA sequence labeled with biotin through competitive binding; then magnetic microspheres coupled with capture probes are added; then reagents coupled with enzyme molecules are added to the magnetic microspheres; the magnetic microspheres are dispersed by microfluidics, and fluorescent substrates are added; finally, the content of T-2 toxin in the sample to be tested is obtained by fluorescence counting. The detection method utilizes the fluorescent signal generated by the enzymatic reaction combined with microfluidics to realize ultrasensitive detection of T-2 toxin at the single molecule level, and has the advantages of small sample dosage and good accuracy, and has great application potential for detecting low-concentration T-2 toxin in cereal samples.
Owner:HENAN BUSINESS SCI RES INST +1

KRAS based on intracellular NMR technology G12C Methods for screening protein-specific binding inhibitors and evaluating ligand competition

This invention belongs to the interdisciplinary field of medicine and structural biology, and relates to a KRAS based on intracellular NMR technology. G12C A method for screening protein-specific binding inhibitors and evaluating ligand competition. Its key feature is that this method is the first to achieve KRAS... G12C This method observes the dynamic binding behavior of proteins in intact living cells, avoiding target conformation distortion caused by traditional cell lysis, and establishes a high-throughput, rapid analysis technique compatible with KRAS. G12C An analytical method for protein-specific binding to ligand inhibitors and competitive binding relationships between ligands. This method has the advantages of high throughput, good stability, wide applicability, and low experimental cost, improving the sensitivity and accuracy of the discovery and screening of ligands with antitumor activity.
Owner:INST OF MATERIA MEDICA CHINESE ACAD OF MEDICAL SCI

A melamine detection method based on DNA hydrogel and microfluidic chip

The present invention belongs to the field of small molecule detection, and provides a melamine detection method and microfluidic chip based on DNA hydrogel. The present invention combines stimulus-responsive DNA hydrogel with microfluidic chip, wherein the DNA hydrogel uses melamine aptamer as a cross-linking agent, and encapsulates nanogold as a basis for colorimetric detection and quantitative analysis. When melamine is present, it competitively binds to its aptamer, resulting in the disintegration of the DNA hydrogel and the release of the encapsulated nanogold, thereby achieving visual detection and quantitative measurement of melamine. Furthermore, a microfluidic chip is introduced in combination with the properties of DNA hydrogel, and quantitative detection of melamine can be achieved by taking pictures and analyzing the grayscale value of the copolymer solution after the reaction according to the different color depths. The method does not require skilled operators or large instruments, and can achieve portable and sensitive on-site detection of the target, and has great potential in food safety, clinical testing, environmental monitoring, etc.
Owner:INST OF ENVIRONMENTAL MEDICINE & OCCUPATIONAL MEDICINE ACAD OF MILITARY MEDICINE ACAD OF MILITARY SCI

Label-free proportional staphylococcus aureus enterotoxin A luminous aptamer biosensor

The invention discloses a label-free proportional type luminous aptamer biosensor for staphylococcus aureus enterotoxin A (SEA). The label-free proportional type luminous aptamer biosensor comprises the following steps: (1) advanced evolution screening of a complex matrix high-adaptability aptamer; (2) rationally cutting the aptamer assisted by computer simulation; (3) a construction strategy of the label-free proportional biosensor; (4) a label-free proportional SEA bifunctional biosensor sequence; (5) optimizing conditions of the label-free proportional SEA biosensor; and (6) SEA detection. The design principle is that fluorescence of SEA and ThT is excited to different degrees on the basis of a competitive binding effect between an SEA target and a small molecule nucleic acid dye thioflavin T (ThT) as well as a luminous nucleic acid aptamer, so that the ratio of fluorescence signals of the SEA and the ThT is in a linear relationship with the target concentration, and finally, rapid, label-free and low-cost proportional fluorescence detection of the SEA is realized.
Owner:CHINA AGRI UNIV

Antigen-binding protein and use thereof

The present application relates to an antigen-binding protein and use thereof, and specifically relates to an antigen-binding protein capable of inhibiting competitive binding of IGF-1R to ligands thereof with an IC50 value of about 1.0 µg / mL or less in a competitive ELISA.
Owner:MINGHUI PHARMA HANGZHOU LTD +1

Drug interaction intelligent prediction method and system based on knowledge graph

The invention provides an intelligent drug interaction prediction method and system based on a knowledge graph, and relates to the technical field of medical information, and the method comprises the steps: extracting drug molecular structure and metabolic data, calculating the conformation overlapping degree, determining a metabolic pathway overlapping site, calculating the competitive binding probability, analyzing the drug distribution state, and judging a metabolic cycle overlapping interval. Determining a concentration accumulation range, evaluating a metabolic inhibition level, generating early warning data and updating the knowledge graph. The drug interaction can be accurately predicted, the medication safety is improved, and the adverse reaction risk is reduced.
Owner:CHANGZHOU NO 2 PEOPLES HOSPITAL

Aptamer screening method

PCT designated stage expiredWO2025137743A1Compound screeningApoptosis detectionCompetitive bindingAnalyte
A method for identifying an aptamer suitable for use in an electrochemical sensor for sensing a target analyte. The method includes determining whether the target analyte competitively binds with the analyte recognition element. Competitive binding in favour of the target analyte is indicative of the suitability of the aptamer.
Owner:NUTROMICS TECHNOLOGY PTY LTD

Monoclonal antibody 6D11 for resisting DENV NS1 protein as well as preparation method and application of monoclonal antibody 6D11

The invention provides a monoclonal antibody 6D11 and application thereof. The CDR amino acid sequence of a heavy chain of the monoclonal antibody 6D11 is shown as SEQ ID No.1, and the CDR amino acid sequence of a light chain of the monoclonal antibody 6D11 is shown as SEQ ID No.2. The invention also provides application of the monoclonal antibody 6D11 in preparation of drugs for treating dengue virus infection, and the monoclonal antibody 6D11 has the advantages of competitive binding of DENV1-4NS1 protein, inhibition of vascular leakage symptom, in vivo protection of DENV infection fatal injury and the like, and has potential huge treatment value of dengue virus resistance.
Owner:SOUTHERN MEDICAL UNIVERSITY

Application of inhibiting combination of Hic-5 and SMAD7 and / or inhibiting Hic-5 in pulmonary arterial hypertension treatment

The invention discloses application of inhibiting combination of Hic-5 and SMAD7 and / or inhibiting Hic-5 in treatment of pulmonary arterial hypertension, and finds that PLEKHH2 and SMAD7 have competitive combination with Hic-5 protein in lung tissue, more SMAD7 can be released into cytoplasm by preventing combination of Hic-5 and SMAD7, and SMAD2 / 3 phosphorylation is inhibited for the first time, so that the purpose of treating the pulmonary arterial hypertension is achieved. The invention provides a new research and development direction for the development of pulmonary arterial hypertension treatment medicines.
Owner:FUWAI HOSPITAL CHINESE ACAD OF MEDICAL SCI & PEKING UNION MEDICAL COLLEGE

A monoclonal antibody 6D11 against DENV NS1 protein, its preparation method and application

This invention provides a monoclonal antibody 6D11 and its applications. The CDR amino acid sequence of the heavy chain of the anti-monoclonal antibody 6D11 is shown in SEQ ID No. 1, and the CDR amino acid sequence of the light chain is shown in SEQ ID No. 2. This invention also provides the application of monoclonal antibody 6D11 in the preparation of drugs for treating dengue virus infection. The monoclonal antibody 6D11 of this invention has advantages such as competitive binding to DENV1-4NS1 protein, inhibition of vascular leakage symptoms, and protection against lethal damage from DENV infection in vivo, and has significant potential therapeutic value against dengue virus.
Owner:SOUTHERN MEDICAL UNIVERSITY

Preparation method and application of an amphiphilic tyrosinase copper competitive binding agent

The application discloses a preparation method and application of an amphiphilic tyrosinase copper competitive binding agent. Two new compounds P4TA or P2TA are synthesized by coupling tyramine TA with 4,4',4'',4'''-(porphyrin-5,10,15,20-tetrayl) tetrakisbenzoic acid TCPP or 3,7,12,17-tetramethyl-8,13-diethyl-2,18-porphyrin dipropionic acid PPIX. An optimal synthesis process of P4TA and P2TA is provided, and an experience is provided for related synthesis. The obtained P4TA and P2TA can recognize tyrosinase and are good copper ion binding reagents, and the two compounds exhibit a significant inhibitory effect on TYR. The application can be used for tyrosinase targeted inhibition and copper ion metabolism intervention in biological medicines and food.
Owner:JIANGSU UNIV

A closed-loop ecological circular agriculture system and method for synergistic bacterial and algal livestock breeding and raising

This invention relates to the field of agricultural ecological cycle technology, specifically disclosing a closed-loop ecological cycle agricultural system and method for synergistic microbial and algal livestock breeding. The system determines the instantaneous toxicity equivalent by collecting ammonia and hydrogen sulfide concentrations in waste gas and parameters of the culture medium, and calculates the target supply concentration of the signal antagonist based on its coupling relationship with the transmembrane proton gradient. The antagonist is injected into the waste gas in a pulsed manner to form drug-loaded bubbles, which are then introduced into the reaction system. During the bubble rise, the antagonist desorbs, forming a concentration gradient, allowing the microbial community and microalgae to complete receptor competitive binding and heat shock protein transcription activation in the same liquid column. The purified effluent is reused for irrigation, and the harvested microbial and algal biomass is returned to the aquaculture as feed additives, achieving a complete closed-loop cycle. This invention solves the problems of existing technologies lacking quantitative assessment and precise intervention methods for reducing gas stress in waste gas, difficulty in dynamically controlling the system based on the real-time tolerance status of microbial and algal species, and the easy residue of exogenous additives affecting feed safety.
Owner:HUNAN XIAORUI AGRI ECOLOGICAL TECH CO LTD

Screening method of targeted Nedd4-2 intermediary hERG potassium channel degradation small-molecule inhibitor and inhibitor thereof

The invention provides a screening method of a targeted Nedd4-2 intermediary hERG potassium channel degradation small-molecule inhibitor and the inhibitor thereof. According to the invention, through a molecular docking virtual screening technology, cell culture, plasmid transfection, an FLIPR ion channel screening technology, a Western Blot technology and a patch clamp technology, a method for high-throughput screening of a targeted Nedd4-2 intermediate hERG potassium channel degradation small molecule inhibitor is established. The screened compound LACCAIC ACID A (number 17) can reduce the degradation of hERG potassium channel on the basis of overexpression of Nedd4-2, increase Ikr current, obviously antagonize the extension of repolarization time history caused by ET-1, and reduce the occurrence rate of cell arrhythmia. The results show that the LACCAIC ACID A compound obtained by the screening method is competitively combined with the PY sequence of the hERG channel with Nedd4-2, so that the ubiquitination degradation of the hERG channel by the Nedd4-2 is reduced, and a research and development basis is provided for further developing hERG potassium channel degradation prevention and treatment drugs.
Owner:HEBEI MEDICAL UNIVERSITY

Compound and application thereof

The invention discloses a compound and application thereof. The invention provides a series of novel compounds with chemical structures reported for the first time. An activity research result shows that the series of novel compounds can competitively inhibit the combination of a natural substrate simulant of an SH2 substructural domain in a Cbl-b TKB structural domain and the SH2 substructural domain in the Cbl-b TKB structural domain. The competitive inhibition effect of the series of novel compounds can reduce the function of the Cbl-b protein, so that the continuous activation of T cells can be caused, and the tumor removal capability mediated by the T cells can be enhanced. Therefore, the series of novel compounds have the prospect of being developed into antitumor drugs. In addition, the series of novel compounds can also be developed into a reagent which is competitively combined with the SH2 substructural domain in the Cbl-b TKB structural domain, and the effect of the reagent includes but is not limited to a competitive inhibitor reference substance of the SH2 substructural domain in the Cbl-b TKB structural domain.
Owner:CHINA PHARM UNIV

A portable detection device and method based on affinity sensor method for detecting mycotoxins

The application discloses a ricin toxin detection sensor based on competitive binding of ricin to mitochondrial adenine nucleotide translocator (ANT) and a detection method, which comprises ANT protein, hollow dialysis fiber, chemical cross-linking agent and fluorescently labeled ATP. When in use, the ANT is first fixed on the inner wall of the hollow fiber dialysis membrane and the fluorescently labeled ATP (cy5-12-ATP or cy3-12-ATP or DEPC-12-ATP) is added; then, it is placed in the to-be-detected solution for 30-60 seconds, and then is placed under a fluorescence detection instrument (such as a fluorescence microscope) for observation, so that the presence or absence of the ricin toxin and the approximate concentration of the toxin are determined; then, the relative intensity of the fluorescence of the to-be-detected solution is determined; a standard curve of the corresponding relationship between the concentration of the fluorescent group and the concentration of the toxin is established; and the concentration of the ricin toxin in the to-be-detected solution is obtained by substituting the concentration of the fluorescent group of the to-be-detected solution into the above standard curve and performing calculation. The application can effectively improve the detection efficiency, simplify the detection method and be widely applied in the society.
Owner:HUNAN UNIV OF SCI & TECH SANYA RES INST

Application of long-chain non-coding RNA Cslnc256 in regulation and control of colletotrichum gloeosporioides resistance post-transcription mechanism of tea trees

The invention discloses an application of long-chain non-coding RNA (Ribonucleic Acid) Cslnc256 in regulating and controlling an anti-colletotrichum gloeosporioides posttranscriptional mechanism of a tea tree. According to the application of the long-chain non-coding RNA Cslnc256 in regulating and controlling the colletotrichum gloeosporioides resisting post-transcription mechanism of the tea tree, the long-chain non-coding RNA Cslnc256 can accurately act on Cslnc256-CsmiR395-CsSultr2 in the tea tree body; therefore, the defense mechanism of the plant is efficiently activated. When the expression of the Cslnc256 is inhibited, the competitive binding capacity of the Cslnc256 and the CsmiR395 is reduced, so that the concentration of the free CsmiR395 is increased, and further, the activity of the Cslnc256 on the target gene CsSultr2; 1 is an inhibitory effect. The regulation and control process can reduce the activity of sulfate transporter protein in the tea tree body, so that sulfate ions are accumulated in leaves, and the sulfate ions serving as important defense signal molecules can effectively improve the resistance of the tea tree to colletotrichum gloeosporioides and relieve scab expansion and tissue damage caused by pathogenic bacterium infection.
Owner:ANHUI AGRICULTURAL UNIVERSITY

A competitive binding method for assessing the interaction between trypsin and flavonoids

The application discloses a competitive binding method for evaluating the interaction between trypsin and flavonoids, wherein the interaction between different flavonoids and trypsin is analyzed by means of electrospray ionization mass spectrometry (ESI-MS) in a competitive mode of mass spectrometry; the parameter R can be introduced to compare the relative strength of the affinity, to judge whether the different flavonoids compete with each other in the binding to trypsin, and to further infer whether the binding sites of the different flavonoids on trypsin are the same; the method is simple, fast and high in accuracy, and can provide a feasible scheme for rapidly screening trypsin inhibitors.
Owner:NANJING NORMAL UNIVERSITY